Results
1 -
10 of
153
(Click
here to explore results)
- Handbook of Culture Media for Food and Water Microbiology (3), Chapter 19 Culture Media for the Isolation of Campylobacters, Helicobacters and Arcobacters. Janet E. L. Corry, H. Ibrahim Atabay
, 2012
, Pages 403-450
- Toxicological Effects of Veterinary Medicinal Products in Humans: Volume 2, Chapter 11 Antifungal Drugs. K. N. Woodward
, 2013
, Volume 2
, Pages 71-94
- Neglected Diseases and Drug Discovery, Chapter 6 Drugs for Kinetoplastid Diseases – Current Situation and Challenges. Simon L. Croft
, 2012
, Pages 134-158
- Nanotoxicology: Experimental and Computational Perspectives, Chapter 4 Protocols for In vitro and In vivo Toxicity Assessment of Engineered Nanoparticles. Ashutosh Kumar, Violet Aileen Senapati, Alok Dhawan
, 2018
, Pages 94-132
- Drug Discovery for Leishmaniasis, I. Appraisal of Leishmaniasis Chemotherapy, Current Status and Pipeline StrategiesChapter 1 Leishmaniasis, Impact and Therapeutic Needs. Jorge Alvar, Byron Arana
, 2018
, Pages 1-23
- Drug Discovery for Leishmaniasis, Chapter 3 From Bench to Bedside: Development and Optimization of Clinical Therapies for Visceral Leishmaniasis. Fabiana Alves, Jean-Yves Gillon, Byron Arana, Thomas P. C. Dorlo
, 2018
, Pages 37-54
- Natural Product Chemistry for Drug Discovery, Chapter 15 Micafungin. Akihiko Fujie, Shuichi Tawara, Seiji Hashimoto
, 2009
, Pages 410-428
- Drug Discovery for Leishmaniasis, Chapter 10 Organometallic Compounds in Chemotherapy Against Leishmania. Bruno Rodrigues do Prado, Arshad Islam, Frédéric Frézard, Cynthia Demicheli
, 2018
, Pages 199-223
- Drug Discovery for Leishmaniasis, Chapter 11 New Avenues for Drug Delivery in Leishmania: Using Treatment of Visceral Leishmaniasis with Amphotericin B as an Exemplar. Katharine C. Carter, Alexander B. Mullen
, 2018
, Pages 224-234
- Drug Discovery for Leishmaniasis, Chapter 18 Molecular Basis of Drug Resistance in Leishmania. Annelies Mondelaers, Sarah Hendrickx, Guy Caljon, Louis Maes
, 2018
, Pages 371-386